Device Trial Radar · NCT03078504
Hemodynamic Effects of Blood Flow Variation in Continuous Renal Replacement Therapy
Last checked: Nov 20, 2026Latest source record: Mar 30, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
6
Actual
Start
Feb 17, 2017
Primary completion
Jun 6, 2018
Study completion Jun 30, 2018
Sponsor
- Lead sponsor
- St. Louis UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 13, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 89 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Purpose of this study is to evaluate the short-term hemodynamic effects of changes in blood flow rates in critically ill patients receiving continuous renal replacement therapy.
Conditions
- Acute Kidney Injury
- End-stage Renal Disease
Interventions
continuous renal replacement therapy using System One (TM) setup (Nxstage)Device
Participants who have been prescribed continuous renal replacement therapy will have hemodynamic parameters measured at various blood flow rates
Primary outcomes
What the sponsor says the trial is designed to measure.
- Blood Pressure ChangeTime frame: 10 minutes
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Saint Louis University
St Louis, Missouri
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.